Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Amantadine emerges as the pharmacologic agent with the most support for improving cognitive impairment after TBI, while cognitive rehabilitation interventions demonstrate substantial evidence for enhancing neurocognitive function and reducing functional limitations.
Emergency Medicine July 30th 2024
The New England Journal of Medicine
Tenecteplase administered up to 24 hours after stroke onset improved functional outcomes in patients with large-vessel occlusion and salvageable brain tissue who lacked access to immediate thrombectomy.
Practical Neurology
A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.
Clinical Pharmacology July 30th 2024
Journal of Neurology, Neurosurgery & Psychiatry
A recent study involving 230 untreated relapsing-remitting MS patients found that vitamin D levels below 20 ng/mL were associated with a more than twofold increase in the risk of disease activity. This finding emphasizes the potential importance of vitamin D monitoring and management in MS patient care.
Neurology July 30th 2024
MDLinx
LANS presents with memory symptoms that mimic Alzheimer’s disease, but brain imaging and biomarkers indicate a different underlying condition, potentially leading to more accurate diagnoses and prognoses for older adults with cognitive decline.
Geriatrics July 30th 2024
Lion’s mane mushroom stimulates nerve growth factor production, potentially supporting neuron growth and survival, with implications for cognitive health and neurological disorders.
Gastroenterology July 30th 2024